Insider Selling: Agilent Technologies, Inc. (NYSE:A) VP Sells 2,746 Shares of Stock

Agilent Technologies, Inc. (NYSE:AGet Rating) VP Padraig Mcdonnell sold 2,746 shares of the firm’s stock in a transaction dated Tuesday, November 22nd. The shares were sold at an average price of $153.21, for a total value of $420,714.66. Following the completion of the transaction, the vice president now owns 16,201 shares of the company’s stock, valued at approximately $2,482,155.21. The sale was disclosed in a document filed with the SEC, which is available through this link.

Padraig Mcdonnell also recently made the following trade(s):

  • On Wednesday, September 28th, Padraig Mcdonnell sold 2,103 shares of Agilent Technologies stock. The stock was sold at an average price of $122.89, for a total transaction of $258,437.67.
  • On Thursday, September 8th, Padraig Mcdonnell sold 2,506 shares of Agilent Technologies stock. The stock was sold at an average price of $134.33, for a total value of $336,630.98.

Agilent Technologies Price Performance

Shares of A traded down $1.51 during trading hours on Thursday, hitting $155.35. 1,444,152 shares of the company were exchanged, compared to its average volume of 1,397,565. The company has a quick ratio of 1.41, a current ratio of 2.03 and a debt-to-equity ratio of 0.52. Agilent Technologies, Inc. has a fifty-two week low of $112.52 and a fifty-two week high of $162.62. The company has a market cap of $45.99 billion, a price-to-earnings ratio of 37.25, a P/E/G ratio of 2.78 and a beta of 1.06. The firm’s fifty day moving average is $133.55 and its 200 day moving average is $128.29.

Agilent Technologies (NYSE:AGet Rating) last announced its quarterly earnings data on Monday, November 21st. The medical research company reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.14. The firm had revenue of $1.85 billion for the quarter, compared to the consensus estimate of $1.76 billion. Agilent Technologies had a net margin of 18.31% and a return on equity of 30.31%. The business’s revenue for the quarter was up 11.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.21 earnings per share. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.64 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 25th. Shareholders of record on Tuesday, January 3rd will be paid a dividend of $0.225 per share. The ex-dividend date of this dividend is Friday, December 30th. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.21. This represents a $0.90 annualized dividend and a yield of 0.58%. Agilent Technologies’s dividend payout ratio is presently 20.14%.

Hedge Funds Weigh In On Agilent Technologies

Several hedge funds and other institutional investors have recently modified their holdings of A. Steward Partners Investment Advisory LLC grew its holdings in shares of Agilent Technologies by 2.5% during the 1st quarter. Steward Partners Investment Advisory LLC now owns 6,570 shares of the medical research company’s stock valued at $869,000 after purchasing an additional 159 shares during the last quarter. abrdn plc grew its stake in shares of Agilent Technologies by 5.6% during the first quarter. abrdn plc now owns 145,835 shares of the medical research company’s stock worth $19,801,000 after buying an additional 7,731 shares during the last quarter. Versor Investments LP increased its holdings in shares of Agilent Technologies by 43.8% during the first quarter. Versor Investments LP now owns 3,020 shares of the medical research company’s stock worth $400,000 after buying an additional 920 shares in the last quarter. Shell Asset Management Co. lifted its stake in shares of Agilent Technologies by 1.0% in the 1st quarter. Shell Asset Management Co. now owns 37,080 shares of the medical research company’s stock valued at $4,907,000 after acquiring an additional 362 shares during the last quarter. Finally, Waldron Private Wealth LLC grew its position in Agilent Technologies by 3.3% during the 1st quarter. Waldron Private Wealth LLC now owns 2,927 shares of the medical research company’s stock worth $387,000 after acquiring an additional 93 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on A. KeyCorp increased their price target on Agilent Technologies from $155.00 to $165.00 and gave the company an “overweight” rating in a research note on Tuesday. Wells Fargo & Company raised their target price on shares of Agilent Technologies from $135.00 to $150.00 in a research note on Tuesday. Robert W. Baird upped their price target on shares of Agilent Technologies from $160.00 to $170.00 in a research note on Tuesday. Citigroup raised their price objective on shares of Agilent Technologies from $145.00 to $150.00 and gave the stock a “neutral” rating in a research report on Tuesday. Finally, Cowen boosted their price objective on Agilent Technologies from $160.00 to $168.00 in a report on Tuesday. Four investment analysts have rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $157.00.

Agilent Technologies Company Profile

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Further Reading

Insider Buying and Selling by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.